EU and US could reach trade deal this weekend - Reuters
Huntsman (NYSE:HUN) Corp., a leader in the chemicals industry, reached a 52-week low on Thursday, with its stock price touching 10.74 USD, marking a dramatic decline from its 52-week high of $25.12. According to InvestingPro analysis, the stock appears undervalued at current levels. This decline marks a significant milestone for the company as it navigates a challenging market environment. Over the past year, Huntsman stock has experienced a stark decrease, with a 1-year change of -53.7%. Despite the challenges, the company maintains a notable 9.17% dividend yield and has sustained dividend payments for 19 consecutive years. This drop reflects broader concerns within the chemicals sector, including fluctuating demand and the impact of raw material costs. Investors are keenly watching how Huntsman will adapt its strategies to address these challenges and work towards a recovery. For deeper insights into Huntsman’s financial health and growth prospects, InvestingPro offers 8 additional key tips and comprehensive analysis.
In other recent news, Huntsman Corporation reported its first-quarter 2025 earnings, revealing a minor miss in both earnings per share and revenue. The company posted an EPS of -$0.11, slightly below the forecast of -$0.10, and revenue came in at $1.41 billion, falling short of the expected $1.5 billion. Additionally, Huntsman Corporation has amended its existing credit agreement to adjust its leverage ratio, allowing for an increased maximum permitted ratio of Consolidated Net Debt to Consolidated EBITDA through December 31, 2026. This move is part of Huntsman’s strategy to manage its leverage and maintain financial flexibility. Jefferies lowered its price target for Huntsman stock from $19.00 to $17.00, while maintaining a Buy rating, due to ongoing softness in construction and automotive demand. The firm expects Huntsman’s second-quarter EBITDA to be near the low end of the $60-$90 million range. Jefferies also projects a delayed cyclical recovery for Huntsman until late 2026-2027. Despite these challenges, Huntsman is doubling its cost savings target to $100 million as part of its strategic positioning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.